RAB29 and Parkinson disease: The co-expression of LRRK2 and RAB29 in the substantia nigra is of particular interest, as RAB29 is a candidate risk gene for Parkinson’s [43], is a putative substrate for LRRK2 kinase activity [44], and may regulate LRRK2 [45,46].